<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.0 20040830//EN" "http://dtd.nlm.nih.gov/publishing/2.0/journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter" dtd-version="2.0">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">JDERM</journal-id>
      <journal-id journal-id-type="nlm-ta">JMIR Dermatol</journal-id>
      <journal-title>JMIR Dermatology</journal-title>
      <issn pub-type="epub">2562-0959</issn>
      <publisher>
        <publisher-name>JMIR Publications</publisher-name>
        <publisher-loc>Toronto, Canada</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">v6i1e47115</article-id>
      <article-id pub-id-type="pmid">37632943</article-id>
      <article-id pub-id-type="doi">10.2196/47115</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Letter</subject>
        </subj-group>
        <subj-group subj-group-type="article-type">
          <subject>Research Letter</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Teledermatology Within Correctional Settings in the United States: A Narrative Review of the Literature</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Dellavalle</surname>
            <given-names>Robert</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="reviewer">
          <name>
            <surname>Long</surname>
            <given-names>Valencia</given-names>
          </name>
        </contrib>
        <contrib contrib-type="reviewer">
          <name>
            <surname>Snoswell</surname>
            <given-names>Centaine</given-names>
          </name>
        </contrib>
        <contrib contrib-type="reviewer">
          <name>
            <surname>Elsanousi</surname>
            <given-names>Yasir</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib id="contrib1" contrib-type="author">
          <name name-style="western">
            <surname>Kamat</surname>
            <given-names>Samir</given-names>
          </name>
          <degrees>MD</degrees>
          <xref rid="aff1" ref-type="aff">1</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0003-0761-231X</ext-link>
        </contrib>
        <contrib id="contrib2" contrib-type="author">
          <name name-style="western">
            <surname>Agarwal</surname>
            <given-names>Aneesh</given-names>
          </name>
          <degrees>MBA</degrees>
          <xref rid="aff1" ref-type="aff">1</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0002-6614-3763</ext-link>
        </contrib>
        <contrib id="contrib3" contrib-type="author">
          <name name-style="western">
            <surname>Klufas</surname>
            <given-names>Timothy</given-names>
          </name>
          <degrees>BA</degrees>
          <xref rid="aff2" ref-type="aff">2</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0009-0009-5684-1443</ext-link>
        </contrib>
        <contrib id="contrib4" contrib-type="author">
          <name name-style="western">
            <surname>Patel</surname>
            <given-names>Saahil</given-names>
          </name>
          <degrees>BS</degrees>
          <xref rid="aff3" ref-type="aff">3</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0003-2025-5281</ext-link>
        </contrib>
        <contrib id="contrib5" contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Lu</surname>
            <given-names>Jun</given-names>
          </name>
          <degrees>MD</degrees>
          <xref rid="aff4" ref-type="aff">4</xref>
          <address>
            <institution>Department of Dermatology</institution>
            <institution>University of Conneticut</institution>
            <addr-line>21 South Road</addr-line>
            <addr-line>Farmington, CT, 06032</addr-line>
            <country>United States</country>
            <phone>1 860 679 4600</phone>
            <email>jlu@uchc.edu</email>
          </address>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0001-9169-6178</ext-link>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <label>1</label>
        <institution>Icahn School of Medicine at Mount Sinai</institution>
        <addr-line>New York City, NJ</addr-line>
        <country>United States</country>
      </aff>
      <aff id="aff2">
        <label>2</label>
        <institution>New York Medical College</institution>
        <addr-line>Valhalla, NY</addr-line>
        <country>United States</country>
      </aff>
      <aff id="aff3">
        <label>3</label>
        <institution>The College of New Jersey</institution>
        <addr-line>Ewing, NJ</addr-line>
        <country>United States</country>
      </aff>
      <aff id="aff4">
        <label>4</label>
        <institution>Department of Dermatology</institution>
        <institution>University of Conneticut</institution>
        <addr-line>Farmington, CT</addr-line>
        <country>United States</country>
      </aff>
      <author-notes>
        <corresp>Corresponding Author: Jun Lu <email>jlu@uchc.edu</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2023</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>26</day>
        <month>5</month>
        <year>2023</year>
      </pub-date>
      <volume>6</volume>
      <elocation-id>e47115</elocation-id>
      <history>
        <date date-type="received">
          <day>8</day>
          <month>3</month>
          <year>2023</year>
        </date>
        <date date-type="rev-request">
          <day>30</day>
          <month>4</month>
          <year>2023</year>
        </date>
        <date date-type="rev-recd">
          <day>7</day>
          <month>5</month>
          <year>2023</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </history>
      <copyright-statement>©Samir Kamat, Aneesh Agarwal, Timothy Klufas, Saahil Patel, Jun Lu. Originally published in JMIR Dermatology (http://derma.jmir.org), 26.05.2023.</copyright-statement>
      <copyright-year>2023</copyright-year>
      <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
        <p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Dermatology, is properly cited. The complete bibliographic information, a link to the original publication on http://derma.jmir.org, as well as this copyright and license information must be included.</p>
      </license>
      <self-uri xlink:href="https://derma.jmir.org/2023/1/e47115" xlink:type="simple"/>
      <kwd-group>
        <kwd>legal</kwd>
        <kwd>patients who are incarcerated</kwd>
        <kwd>vulnerable populations</kwd>
        <kwd>teledermatology</kwd>
        <kwd>volunteerism</kwd>
        <kwd>correctional</kwd>
        <kwd>teleconsultation</kwd>
        <kwd>telemedicine</kwd>
        <kwd>eHealth</kwd>
        <kwd>skin disorders</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>Teledermatology is an emerging modality of care delivery. To broadly understand the role of teledermatology in the US correctional system, we conducted a narrative review using PubMed, Scopus, Embase, and gray literature. We identified 5 studies (<xref rid="figure1" ref-type="fig">Figure 1</xref>) analyzing over 1261 teledermatology encounters within correctional settings in the United States (summary characteristics are in <xref ref-type="table" rid="table1">Table 1</xref>; the search strategy used is in <xref ref-type="supplementary-material" rid="app1">Multimedia Appendix 1</xref>).</p>
    <p>The first published study on the use of teledermatology for incarcerated populations was in 1996 from East Carolina University in Greenville, North Carolina [<xref ref-type="bibr" rid="ref1">1</xref>]. Since then, several single-center observational and cohort studies have reported the implementation of teledermatology across several localities, including Utah and Connecticut [<xref ref-type="bibr" rid="ref2">2</xref>-<xref ref-type="bibr" rid="ref4">4</xref>]. All studies have indicated the partnership between the dermatology providers and the state prison system. The Federal Bureau of Prisons (BOP) also established a teledermatology program in 2012 covering over 50 institutions. The collaboration between dermatologists and a government agency is critical and unique for teledermatology in correctional settings [<xref ref-type="bibr" rid="ref5">5</xref>].</p>
    <p>Teledermatology has proven to improve access to care and efficiently diagnose a broad spectrum of skin disorders, particularly inflammatory conditions, and skin infections. Common diagnoses reported included cutaneous infection [<xref ref-type="bibr" rid="ref4">4</xref>], acne (9%-14.9%) [<xref ref-type="bibr" rid="ref2">2</xref>-<xref ref-type="bibr" rid="ref4">4</xref>], eczema (9.3%-18%) [<xref ref-type="bibr" rid="ref2">2</xref>-<xref ref-type="bibr" rid="ref4">4</xref>], psoriasis (28.1%) [<xref ref-type="bibr" rid="ref3">3</xref>-<xref ref-type="bibr" rid="ref4">4</xref>], and prurigo nodularis or lichen simplex chronicus (10%) [<xref ref-type="bibr" rid="ref2">2</xref>]. One study showed that 86.3% of cases could be managed via teledermatology alone, with 86% of patients prescribed new topical therapeutics and 57.9% receiving systemic therapies, including biologics [<xref ref-type="bibr" rid="ref4">4</xref>]. Medical management via teledermatology was confirmed to be successful and continued to serve patients well according to medical records [<xref ref-type="bibr" rid="ref4">4</xref>]. When compared with face-to-face visit cohorts, teledermatology cohorts involved more medication recommendations (84.8% vs 48.4%; <italic>P</italic>&#60;.001) and fewer procedures and referrals (<italic>P</italic>&#60;.001), likely resulting from appropriate triage by a prison primary care physician [<xref ref-type="bibr" rid="ref3">3</xref>].</p>
    <p>Different teledermatology modalities have been adopted. Live videoconference is the most commonly implemented modality via various videoconference platforms, including Picture Tel, Skype, Zoom, etc. Store-and-forward has also been used alone or in combination with live video teledermatology (<xref ref-type="table" rid="table1">Table 1</xref>). Due to a lack of private internet access for inmates, all teledermatology encounters were conducted via institution health care staff, the provider-to-provider module. Teledermatology and face-to-face encounters can be transitioned both ways. Patients who need procedures or biopsies for diagnosis often require face-to-face visits but may transfer back to teledermatology for continuous care after surgery or a definite diagnosis [<xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref4">4</xref>].</p>
    <p>In addition to improved access, teledermatology in one program decreased wait time with an average turnover time of 1-2 weeks compared with 4-12 weeks for an in-person consultation [<xref ref-type="bibr" rid="ref5">5</xref>]. The economic benefits are significant. According to the BOP report, there is an average of US $895 in savings per teledermatology consult from administration costs, particularly regarding securing transportation [<xref ref-type="bibr" rid="ref5">5</xref>].</p>
    <p>Overall, patients who are incarcerated are an underserved population with limited access to specialty care. Teledermatology has increased access and shown capability in addressing wide-spectrum conditions with economic benefits. Future teledermatology initiatives in correctional settings may prioritize high-quality photographs with video, integrate teledermoscopy to aid in diagnosing, emphasize the continuity of care, and expand to more sites.</p>
    <fig id="figure1" position="float">
      <label>Figure 1</label>
      <caption>
        <p>PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses): teledermatology in correctional settings.</p>
      </caption>
      <graphic xlink:href="derma_v6i1e47115_fig1.png" alt-version="no" mimetype="image" position="float" xlink:type="simple"/>
    </fig>
    <table-wrap position="float" id="table1">
      <label>Table 1</label>
      <caption>
        <p>Studies reporting on the use of teledermatology in correctional settings.</p>
      </caption>
      <table width="1000" cellpadding="5" cellspacing="0" border="1" rules="groups" frame="hsides">
        <col width="120"/>
        <col width="170"/>
        <col width="170"/>
        <col width="290"/>
        <col width="250"/>
        <thead>
          <tr valign="top">
            <td>Study</td>
            <td>Population/sample</td>
            <td>Type of consultation</td>
            <td>Results</td>
            <td> Conclusion</td>
          </tr>
        </thead>
        <tbody>
          <tr valign="top">
            <td>Norton et al [<xref ref-type="bibr" rid="ref1">1</xref>], 1997</td>
            <td>189 teleconsultations</td>
            <td>Live video (REACH-TV)</td>
            <td>
              <list list-type="bullet">
                <list-item>
                  <p>Most common diagnosis included: eczema, appendageal disorders, papulosquamous disorders</p>
                </list-item>
                <list-item>
                  <p>Cost saving of US $1000 per visit</p>
                </list-item>
                <list-item>
                  <p>355 specific treatment recommendations</p>
                </list-item>
                <list-item>
                  <p>66 diagnostic recommendations</p>
                </list-item>
              </list>
            </td>
            <td>Remote visits yielded monetary and time savings compared to resources needed for face-to-face visits</td>
          </tr>
          <tr valign="top">
            <td>Phillips et al [<xref ref-type="bibr" rid="ref2">2</xref>], 1996</td>
            <td>138 teleconsultations</td>
            <td>Live video (Picture Tel 4000)</td>
            <td>
              <list list-type="bullet">
                <list-item>
                  <p>159 diagnoses and 252 treatments</p>
                </list-item>
                <list-item>
                  <p>Eczema and acne common diagnosis</p>
                </list-item>
                <list-item>
                  <p>72% African American/average age 32 years</p>
                </list-item>
              </list>
            </td>
            <td>Provider confidence in diagnostic capabilities and ability to successfully manage patient care</td>
          </tr>
          <tr valign="top">
            <td>Clark et al [<xref ref-type="bibr" rid="ref3">3</xref>], 2021</td>
            <td>779 encounters from 359 patients (335 teleconsultations, 444 face-to-face)</td>
            <td>Live video vs face-to-face</td>
            <td>
              <list list-type="bullet">
                <list-item>
                  <p>Psoriasis (28.1%), acne (14.9%), unspecified rash (9.3%)</p>
                </list-item>
                <list-item>
                  <p>Teledermatology less likely led to secondary diagnosis (52% vs 26.3%; <italic>P</italic>&#60;.001)</p>
                </list-item>
                <list-item>
                  <p>Teledermatology more likely to prescribe medication (84.8% vs 48.4%; <italic>P</italic>&#60;.001) but less likely to get referred for procedures (<italic>P</italic>&#60;.001)</p>
                </list-item>
                <list-item>
                  <p>The average teledermatology follow-up period was 2.3 months vs 4.8 months for face-to-face visits (<italic>P</italic>&#60;.001)</p>
                </list-item>
              </list>
            </td>
            <td>Cost-effective for managing common skin conditions. Success with managing severe psoriasis and acne even when using systemic treatments and lab monitoring.</td>
          </tr>
          <tr valign="top">
            <td>Stoj and Lu [<xref ref-type="bibr" rid="ref4">4</xref>], 2021</td>
            <td>98 teleconsultations</td>
            <td>Live video (Skype) and store-and-forward</td>
            <td>
              <list list-type="bullet">
                <list-item>
                  <p>Teledermatology diagnoses: 78.1% (57/73) new diagnoses, and 17 consistent with established diagnoses</p>
                </list-item>
                <list-item>
                  <p>86.3% (63/73) diagnoses involved only telemedicine after initial diagnosis</p>
                </list-item>
                <list-item>
                  <p>Face-to-face was required for 21.9% (16/73) and 13/16 being subsequently managed with telemedicine</p>
                </list-item>
              </list>
            </td>
            <td>Effective for diagnosing and managing acute and chronic dermatological conditions including those that require systemic treatment</td>
          </tr>
          <tr valign="top">
            <td>Federal Bureau of Prisons (website) [<xref ref-type="bibr" rid="ref5">5</xref>], 2014</td>
            <td>Per 2014, 50+ institutions across the Bureau of Prisons, 501 consults in 2013</td>
            <td>Store-and-forward</td>
            <td>
              <list list-type="bullet">
                <list-item>
                  <p>US $448,395 annual savings</p>
                </list-item>
                <list-item>
                  <p>Teledermatology consultation wait time 1-2 weeks in correctional setting vs 30-90 days in correctional setting</p>
                </list-item>
                <list-item>
                  <p>Identifying optimal medications via efficacy and costs considerations</p>
                </list-item>
                <list-item>
                  <p>Average saving of US $895 per visit</p>
                </list-item>
              </list>
            </td>
            <td>Significant savings, reduction in wait times, continuity of care, and expanded reach to geographically inaccessible or rural areas</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
  </body>
  <back>
    <app-group>
      <supplementary-material id="app1">
        <label>Multimedia Appendix 1</label>
        <p>Search strategy.</p>
        <media xlink:href="derma_v6i1e47115_app1.docx" xlink:title="DOCX File , 17 KB"/>
      </supplementary-material>
    </app-group>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term id="abb1">BOP</term>
          <def>
            <p>Bureau of Prisons</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <fn-group>
      <fn fn-type="conflict">
        <p>None declared.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="ref1">
        <label>1</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Norton</surname>
              <given-names>SA</given-names>
            </name>
            <name name-style="western">
              <surname>Burdick</surname>
              <given-names>AE</given-names>
            </name>
            <name name-style="western">
              <surname>Phillips</surname>
              <given-names>CM</given-names>
            </name>
            <name name-style="western">
              <surname>Berman</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Teledermatology and underserved populations</article-title>
          <source>Arch Dermatol</source>
          <year>1997</year>
          <month>02</month>
          <volume>133</volume>
          <issue>2</issue>
          <fpage>197</fpage>
          <lpage>200</lpage>
          <pub-id pub-id-type="medline">9041833</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Phillips</surname>
              <given-names>CM</given-names>
            </name>
            <name name-style="western">
              <surname>Murphy</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Burke</surname>
              <given-names>WA</given-names>
            </name>
            <name name-style="western">
              <surname>Laing</surname>
              <given-names>VB</given-names>
            </name>
            <name name-style="western">
              <surname>Jones</surname>
              <given-names>BE</given-names>
            </name>
            <name name-style="western">
              <surname>Balch</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Gustke</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Dermatology teleconsultations to Central Prison: experience at East Carolina University</article-title>
          <source>Telemed J</source>
          <year>1996</year>
          <volume>2</volume>
          <issue>2</issue>
          <fpage>139</fpage>
          <lpage>43</lpage>
          <pub-id pub-id-type="doi">10.1089/tmj.1.1996.2.139</pub-id>
          <pub-id pub-id-type="medline">10165356</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Clark</surname>
              <given-names>JJ</given-names>
            </name>
            <name name-style="western">
              <surname>Snyder</surname>
              <given-names>AM</given-names>
            </name>
            <name name-style="western">
              <surname>Sreekantaswamy</surname>
              <given-names>SA</given-names>
            </name>
            <name name-style="western">
              <surname>Petersen</surname>
              <given-names>MJ</given-names>
            </name>
            <name name-style="western">
              <surname>Lewis</surname>
              <given-names>BK</given-names>
            </name>
            <name name-style="western">
              <surname>Secrest</surname>
              <given-names>AM</given-names>
            </name>
            <name name-style="western">
              <surname>Florell</surname>
              <given-names>SR</given-names>
            </name>
          </person-group>
          <article-title>Dermatologic care of incarcerated patients: a single-center descriptive study of teledermatology and face-to-face encounters</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2021</year>
          <month>12</month>
          <volume>85</volume>
          <issue>6</issue>
          <fpage>1660</fpage>
          <lpage>1662</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jaad.2020.12.076</pub-id>
          <pub-id pub-id-type="medline">33434597</pub-id>
          <pub-id pub-id-type="pii">S0190-9622(21)00099-2</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Stoj</surname>
              <given-names>V</given-names>
            </name>
            <name name-style="western">
              <surname>Lu</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Comment on: "The growth of teledermatology: Expanding to reach the underserved"</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2021</year>
          <month>08</month>
          <volume>85</volume>
          <issue>2</issue>
          <fpage>e105</fpage>
          <lpage>e106</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jaad.2021.03.100</pub-id>
          <pub-id pub-id-type="medline">33823197</pub-id>
          <pub-id pub-id-type="pii">S0190-9622(21)00668-X</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <nlm-citation citation-type="web">
          <article-title>Teledermatology program improves dermatologic care</article-title>
          <source>Federal Bureau of Prisons</source>
          <access-date>2023-05-02</access-date>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.bop.gov/resources/news/20140407_teledermatology.jsp">https://www.bop.gov/resources/news/20140407_teledermatology.jsp</ext-link>
          </comment>
        </nlm-citation>
      </ref>
    </ref-list>
  </back>
</article>
